Family history of hormonal cancers and colorectal cancer risk: A case-control study conducted in Ontario

International Journal of Cancer

Volumn 125, Issue 4, 2009, Pages 918-925

  Jang, Ji Hyun ^a,b   Cotterchio, Michelle ^a,b   Gallinger, Steven ^c,d   Knight, Julia A ^a,d   Daftary, Darshana ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b Population Studies and Surveillance   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Cancer; Case control study; Colorectal neoplasms; Familial aggregation; Family history

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANADA; CANCER EPIDEMIOLOGY; CANCER RISK; CASE CONTROL STUDY; COLORECTAL CANCER; CONFIDENCE INTERVAL; CONTROL GROUP; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; FAMILY HISTORY; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OVARY CANCER; POPULATION; PRIORITY JOURNAL; PROSTATE CANCER; STATISTICAL SIGNIFICANCE;

AGE FACTORS; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; ENDOMETRIAL NEOPLASMS; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; ONTARIO; OVARIAN NEOPLASMS; PROGNOSIS; PROSTATIC NEOPLASMS; RISK FACTORS; SEX FACTORS;

EID: 67650079904     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24385     Document Type: Article

References (61)

1. Canadian Cancer Society/National Cancer Institute of Canada. Canadian cancer statistics 2008. Toronto, Canada: Canadian Cancer Society, 2008.
2. Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med 2003;348:919-32.
3. de la Chapelle A. Genetic predisposition to colorectal cancer. Nat Rev Cancer 2004;4:769-80.
4. Houlston RS, Tomlinson IP. Polymorphisms and colorectal tumor risk. Gastroenterology 2001;121:282-301.
5. Colditz GA, Atwood KA, Emmons K, Monson RR, Willett WC, Trichopoulos D, Hunter DJ. Harvard report on cancer prevention IV: Harvard cancer risk index. Risk index working group, Harvard center for cancer prevention. Cancer Causes Control 2000;11:477-88.
6. Kerber RA, Slattery ML, Potter JD, Caan BJ, Edwards SL. Risk of colon cancer associated with a family history of cancer or colorectal polyps: the diet, activity, and reproduction in colon cancer study. Int J Cancer 1998;78:157-60.
7. Slattery ML, Levin TR, Ma K, Goldgar D, Holubkov R, Edwards S. Family history and colorectal cancer: predictors of risk. Cancer Causes Control 2003;14:879-87.
8. Le Marchand L, Zhao LP, Quiaoit F, Wilkens LR, Kolonel LN. Family history and risk of colorectal cancer in the multiethnic population of Hawaii. Am J Epidemiol 1996;144:1122-8.
9. Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Speizer FE, Willett WC. A prospective study of family history and the risk of colorectal cancer. N Engl J Med 1994;331:1669-74.
10. Kotake K, Koyama Y, Nasu J, Fukutomi T, Yamaguchi N. Relation of family history of cancer and environmental factors to the risk of colorectal cancer: a case-control study. Jpn J Clin Oncol 1995;25:195-202.
11. Zeegers MP, Schouten LJ, Goldbohm RA, van den Brandt PA. A compendium of familial relative risks of cancer among first degree relatives: a population-based study. Int J Cancer 2008;123:1664-73.
12. Fernandez E, Gallus S, La Vecchia C, Talamini R, Negri E, Franceschi S. Family history and environmental risk factors for colon cancer. Cancer Epidemiol Biomarkers Prev 2004;13:658-61.
13. Nelson CL, Sellers TA, Rich SS, Potter JD, McGovern PG, Kushi LH. Familial clustering of colon, breast, uterine, and ovarian cancers as assessed by family history. Genet Epidemiol 1993;10:235-44.
14. Niell BL, Rennert G, Bonner JD, Almog R, Tomsho LP, Gruber SB. BRCA1 and BRCA2 founder mutations and the risk of colorectal cancer. J Natl Cancer Inst 2004;96:15-21.
15. La Vecchia C, Negri E, Franceschi S, Gentile A. Family history and the risk of stomach and colorectal cancer. Cancer 1992;70:50-5.
16. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 1994;86:1600-8.
17. Phipps RF, Perry PM. Familial breast cancer and the association with colonic carcinoma. Eur J Surg Oncol 1989;15:109-11.
18. Negri E, Braga C, La Vecchia C, Franceschi S, Filiberti R, Montella M, Falcini F, Conti E, Talamini R. Family history of cancer and risk of colorectal cancer in Italy. Br J Cancer 1998;77:174-9.
19. Slattery ML, Kerber RA. Family history of cancer and colon cancer risk: the Utah population database. J Natl Cancer Inst 1994;86:1618-26.
20. Vaittinen P, Hemminki K. Familial cancer risks in offspring from discordant parental cancers. Int J Cancer 1999;81:12-19.
21. Dong C, Hemminki K. Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families. Int J Cancer 2001;92:144-50.
22. Campbell PT, Newcomb P, Gallinger S, Cotterchio M, McLaughlin JR. Exogenous hormones and colorectal cancer risk in Canada: associations stratified by clinically defined familial risk of cancer. Cancer Causes Control 2007;18:723-33.
23. Slattery ML, Sweeney C, Murtaugh M, Ma KN, Wolff RK, Potter JD, Caan BJ, Samowitz W. Associations between ERalpha, ERbeta, and AR genotypes and colon and rectal cancer. Cancer Epidemiol Biomarkers Prev 2005;14:2936-42.
24. Kabat GC, Miller AB, Rohan TE. Oral contraceptive use, hormone replacement therapy, reproductive history and risk of colorectal cancer in women. Int J Cancer 2008;122:643-6.
25. Hannaford P, Elliott A. Use of exogenous hormones by women and colorectal cancer: evidence from the Royal College of General Practitioners' Oral Contraception Study. Contraception 2005;71:95-8.
26. Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, Hubbell FA, Ascensao J, Rodabough RJ, Rosenberg CA, Taylor VM, Harris R, Chen C, Adams-Campbell LL, White E, et al. Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med 2004;350:991-1004.
27. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative Randomized Controlled Trial. JAMA 2002;288:321-33.
28. Grodstein F, Martinez ME, Platz EA, Giovannucci E, Colditz GA, Kautzky M, Fuchs C, Stampfer MJ. Postmenopausal hormone use and risk for colorectal cancer and adenomas. Ann Intern Med 1998;128:705-12.
29. Fernandez E, La Vecchia C, D'Avanzo B, Franceschi S, Negri E, Parazzini F. Oral contraceptives, hormone replacement therapy and the risk of colorectal cancer. Br J Cancer 1996;73:1431-5.
30. Gerhardsson de Verdier M, London S. Reproductive factors, exogenous female hormones, and colorectal cancer by subsite. Cancer Causes Control 1992;3:355-60.
31. Cotterchio M, McKeown-Eyssen G, Sutherland H, Buchan G, Aronson M, Easson AM, Macey J, Holowaty E, Gallinger S. Ontario familial colon cancer registry: methods and first-year response rates. Chronic Dis Can 2000;21:81-6.
32. Newcomb PA, Baron J, Cotterchio M, Gallinger S, Grove J, Haile R, Hall D, Hopper JL, Jass J, Le Marchand L, Limburg P, Lindor N, et al. Colon cancer family registry: an international resource for studies of the genetic epidemiology of colon cancer. Cancer Epidemiol Biomarkers Prev 2007;16:2331-43.
33. World Health Organization. Manual of the international statistical classification of disease, injuries, and causes of death, 9th revision conference. Geneva: World Health Organization, 1977.
34. Vasen HF, Mecklin JP, Khan PM, Lynch HT. The international collaborative group on hereditary non-polyposis colorectal cancer (ICG-HNPCC). Dis Colon Rectum 1991;34:424-5.
35. Love RR, Evans AM, Josten DM. The accuracy of patient reports of a family history of cancer. J Chronic Dis 1985;38:289-93.
36. Douglas FS, O'Dair LC, Robinson M, Evans DG, Lynch SA. The accuracy of diagnoses as reported in families with cancer: a retrospective study. J Med Genet 1999;36:309-12.
37. Ziogas A, Anton-Culver H. Validation of family history data in cancer family registries. Am J Prev Med 2003;24:190-8.
38. Theis B, Boyd N, Lockwood G, Tritchler D. Accuracy of family cancer history in breast cancer patients. Eur J Cancer Prev 1994;3:321-7.
39. Bondy ML, Strom SS, Colopy MW, Brown BW, Strong LC. Accuracy of family history of cancer obtained through interviews with relatives of patients with childhood sarcoma. J Clin Epidemiol 1994;47:89-96.
40. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health 1989;79:340-9.
41. Cotterchio M, Manno M, Klar N, McLaughlin J, Gallinger S. Colorectal screening is associated with reduced colorectal cancer risk: a case-control study within the population-based Ontario Familial Colorectal Cancer Registry. Cancer Causes Control 2005;16:865-75.
42. Ponz de Leon M, Sassatelli R, Sachetti C, Zanghieri G, Scalmati A, Roncucci L. Familial aggregation of tumors in the three-year experience of a population-based colorectal cancer registry. Cancer Res 1989;49:4344-8.
43. Mahavni V, Sood AK. Hormone replacement therapy and cancer risk. Curr Opin Oncol 2001;13:384-9.
44. Gambacciani M, Monteleone P, Sacco A, Genazzani AR. Hormone replacement therapy and endometrial, ovarian and colorectal cancer. Best Pract Res Clin Endocrinol Metab 2003;17:139-47.
45. Bernstein L. The risk of breast, endometrial and ovarian cancer in users of hormonal preparations. Basic Clin Pharmacol Toxicol 2006;98:288-96.
46. Purdie DM, Green AC. Epidemiology of endometrial cancer. Best Pract Res Clin Obstet Gynaecol 2001;15:341-54.
47. Burkman RT, Collins JA, Shulman LP, Williams JK. Current perspectives on oral contraceptive use. Am J Obstet Gynecol 2001;185:S4-12.
48. La Vecchia C. Oral contraceptives and ovarian cancer: an update, 1998-2004. Eur J Cancer Prev 2006;15:117-24.
49. La Vecchia C, Bosetti C. Benefits and risks of oral contraceptives on cancer. Eur J Cancer Prev 2004;13:503-8.
50. Carruba G. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario. J Cell Biochem 2007;102:899-911.
51. Ricke WA, Wang Y, Cunha GR. Steroid hormones and carcinogenesis of the prostate: the role of estrogens. Differentiation 2007;75:871-82.
52. Härkönen PL, Mäkelä SI. Role of estrogens in development of prostate cancer. J Steroid Biochem Mol Biol 2004;92:297-305.
53. Haiman CA, Le Marchand L, Yamamato J, Stram DO, Sheng X, Kolonel LN, Wu AH, Reich D, Henderson BE. A common genetic risk factor for colorectal and prostate cancer. Nat Genet 2007;39:954-6.
54. Ghoussaini M, Song H, Koessler T, Al Olama AA, Kote-Jarai Z, Driver KE, Pooley KA, Ramus SJ, Kjaer SK, Hogdall E, DiCioccio RA, Whittemore AS, et al. Multiple loci with different cancer specificities within the 8q24 gene desert. J Natl Cancer Inst 2008;100:962-6.
55. Rokavec M, Justenhoven C, Schroth W, Istrate MA, Haas S, Fischer HP, Vollmert C, Illig T, Hamann U, Ko YD, Glavac D, Brauch H. A novel polymorphism in the promoter region of ERBB4 is associated with breast and colorectal cancer risk. Clin Cancer Res 2007;13:7506-14.
56. Kerber RA, Slattery ML. Comparison of self-reported and database-linked family history of cancer data in a case-control study. Am J Epidemiol 1997;146:244-8.
57. Sijmons RH, Boonstra AE, Reefhuis J, Hordijk-Hos JM, de Walle HE, Oosterwijk JC, Cornel MC. Accuracy of family history of cancer: clinical genetic implications. Eur J Hum Genet 2000;8:181-6.
58. Verkooijen HM, Fioretta G, Chappuis PO, Vlastos G, Sappino AP, Benhamou S, Bouchardy C. Set-up of a population-based familial breast cancer registry in Geneva, Switzerland: validation of first results. Ann Oncol 2004;15:350-3.
59. King TM, Tong L, Pack RJ, Spencer C, Amos CI. Accuracy of family history of cancer as reported by men with prostate cancer. Urology 2002;59:546-50.
60. Parent ME, Ghadirian P, Lacroix A, Perret C. Accuracy of reports of familial breast cancer in a case-control series. Epidemiology 1995;6:184-6.
61. Ramji F, Cotterchio M, Manno M, Rabeneck L, Gallinger S. Association between subject factors and colorectal cancer screening participation in Ontario, Canada. Cancer Detect Prev 2005;29:221-6.